Hims & Hers Health: sell signal under pressure as confirmation week closes bullish
At week 3 of a sell signal, Hims & Hers Health closed the confirmation week bullish: discipline points to exiting the short position. New entries not recommended: a strong daily double bottom and elevated volatility make the picture ambiguous.
Hera: decline underway, distribution confirmed but minimal drop
Hera is at week 5 of the sell signal with a 3% gain on the trade. The week closed with a minimal drop, but CMF remains in distribution and bearish pressure has not eased: the double bottom in the 3.7 area is the key level to watch.
Home Depot: strong technical rebound, but the decline isn't over
At week 14 of the sell signal, Home Depot rebounds 5.7% with buy volume at 89%: technical indicators show a broad recovery, but the weekly bearish structure has not reversed.
Halliburton: +49% in 33 weeks, double bottom forming
Halliburton is at week 33 of a long opened in 2025: the model's coverage is complete and the residual position continues with a trailing stop on the Inversion Point. This week a daily double bottom in the 39 area holds the line.
Goldman Sachs: 3 targets already hit, now managing the final stretch
Goldman Sachs is at week 9 of a buy trade up 17% from entry. All 3 targets of our most advanced model have already been hit: next week brings the final management window.
Groupon: 2 targets hit in 8 weeks, the third still open
Groupon is at week 8 of a buy signal with a 19.70% gain from entry. 2 of the 3 statistical targets of our most advanced model have already been hit. The stop is now at breakeven: trade risk is zeroed out.